Allogeneic mesenchymal stem cell (MSC) injection therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic mesenchymal stem cell (MSC) injection therapy, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments [Phase 2]